Average Daily Dose per Person per Year of Haloperidol, Risperidone, Zopiclone, Hydroxyzine, Oxazepam, or Paracetamol
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Average daily dose per person per year of haloperidol, risperidone, zopiclone, hydroxyzine, oxazepam, or paracetamol.
Numerator
Average daily dose per person per year of haloperidol, risperidone, zopiclone, hydroxyzine, oxazepam, or paracetamol.
Denominator
All patients.
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
County/municipality/district.
Data Attributes
Type of Data Collection
Data Collection Methods
Data entered by participating sites into a secure online platform.
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Online at pharos.skane.se/bpsddataportal/, and annual reports.
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
2022 Annual report downloaded from web.archive.org/web/20241005070034/https://bpsd.se/styrgruppen/ (in swedish) Strohmaier C and Gassner L. Quality Registries in Dementia Care: Mapping of Registries to improve Quality and Service Delivery. AIHTA Project Report No.: 150; 2022. Vienna: HTA Austria – Austrian Institute for Health Technology Assessment GmbH.